VEGFA and hepatocellular carcinoma: Our results provide evidences of therapeutic efficiency of LNC188Re-SSS with a reduction in tumor progression which could be combinated with an altered angiogenesis process as indicated by VEGF quantifications in plasmatic samples in a rat HCC model.